Vertical Payers: “Highly Integrated” by 2026

Article

Vertical Payers: “Highly Integrated” by 2026

July 18, 2024
Authors
Topics

Welcome to our Monthly Insight Series July 2024 edition! This month we discuss our 2024 research regarding the ever-rising integration across vertical payers’ health plans, PBMs, and SPs, including around manufacturer contracting.

Vertical stacked puzzle pieces

HMP Market Access Insights (MAI) has been reporting on vertical payer integration since the inception of our primary payer research arm in 2022. Every year, we hear how these national players intend to further enhance their internal integration regarding business operations, policy decision making, and data sharing. However, this year we see a greater than normal ‘bump’ for what the future holds. In short, vertical payers anticipate a very high degree of integration within these critically important areas over the next few years (Figure).

Graph


Figure. Percentage of 2024 Vertical Payer Respondents Selecting “High” or “Full” Integration (N = 25).
Source: HMP Market Access Insights 2024 Payer Annual Oncology Trend Report.

  • Manufacturer contracting—greatest increase: The most anticipated area of increased integration is in contracting with manufacturers for rebates and discounts. Related data also show a 48% increase in the number of vertical payer respondents anticipating their level of integration in this area going from “None/Little/Moderate” to “High/Full.”
  • Internal data sharing—empowering payer leverage: Often related to manufacturer contracting, our respondents expect much greater integrated internal sharing of drug utilization data. Through interviews, we also know that aggregated drug-level clinical outcomes, adherence, and other data will be analyzed across entities, too.
  • Health plan vs pharmacy benefit manager (PBM): Within each vertical payer organization, respondents from the PBM entity tend to anticipate lower levels of integration in each of the 4 areas investigated than respondents from the health plan entity.

We look forward to sharing additional insights later this summer when we release our full 2024 Payer Annual Trend Report, part of our suite of Oncology Customer Insights offerings!

Be sure to check out the other reports from HMP MAI:

In the interim, please feel free to reach out to Sara Stewart with any questions you may have!

The Latest

Meet Ashutosh Sheth
Article
Meet Ashu: Organizer & Researcher Extraordinaire; Artist at Heart

Ashu is the glue that keeps our team organized and running smoothly. This year, he’s been particularly fascinated by the growing consolidation among community practices and how it’s reshaping the oncology landscape.

Ashutosh Sheth
Beyond AMCs: CAR Ts and Bispecifics in Community Oncology
Article
Beyond AMCs: CAR Ts and Bispecifics in Community Oncology

CAR T-cell and BsAb therapies are powerful but largely confined to AMCs, limiting patient access. Our latest report explores how expanding to community oncology could improve access, addressing key clinical, logistical, and financial challenges.

Chris Van Denburg
Not only does Emma have over a decade of experience supporting academic health systems and integrated delivery networks (IDNs), but she’s also the go-to for a delicious apple pie.
Article
Meet Emma: Research Leader and Master Baker

Not only does Emma have over a decade of experience supporting academic health systems and integrated delivery networks (IDNs), but she’s also the go-to for a delicious apple pie.

Emma Bijesse